STRAUMANN HLDG CHF0.10 (NASDAQ:SAUHF) was upgraded by Zacks Investment Research from a “hold” rating to a “strong-buy” rating in a report released on Wednesday. The firm presently has a $797.00 price objective on the stock. Zacks Investment Research‘s target price indicates a potential upside of 13.83% from the stock’s current price.

According to Zacks, “The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners. “

Shares of STRAUMANN HLDG CHF0.10 (NASDAQ SAUHF) traded down $0.35 during midday trading on Wednesday, hitting $700.15. 4 shares of the stock were exchanged.

ILLEGAL ACTIVITY WARNING: This piece of content was originally posted by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece of content can be viewed at

Receive News & Ratings for STRAUMANN HLDG CHF0.10 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STRAUMANN HLDG CHF0.10 and related companies with Analyst Ratings Network's FREE daily email newsletter.